| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004046129A3 Novel anthranilamide insecticides |
| 07/15/2004 | WO2004026248A3 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138450 Agriculture salts and oxides |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138274 Novel pharmaceuticals |
| 07/15/2004 | US20040138265 Carboxamides as fungicides in agriculture |
| 07/15/2004 | US20040138261 such as arthritis, pain, fever or cancer; 5-phenyl-1-[3,5-difluoro-4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole for example; cyclooxygenase-2 inhibitors |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138216 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
| 07/15/2004 | US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks |
| 07/15/2004 | DE10361423A1 Preparation of arylethynyl-pyrazole derivatives used as drug and agrochemical intermediates, by converting acetyl-pyrazole into new ethynyl-pyrazole, then reacting with aryl halide |
| 07/15/2004 | DE10300124A1 Verfahren zur Herstellung von Arylalkinen A process for preparing arylalkynes |
| 07/15/2004 | CA2511199A1 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/15/2004 | CA2509833A1 1-alkyl-3-aminoindazoles |
| 07/14/2004 | EP1437347A2 Process for the preparation of arylvinyl halides and aralkinyl compounds |
| 07/14/2004 | EP1437137A1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1436285A2 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436265A2 Chemical compounds |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | CN1512987A Novel 1H-indazole compound |
| 07/14/2004 | CN1512986A Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid |
| 07/08/2004 | WO2004056806A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases |
| 07/08/2004 | WO2004056787A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors |
| 07/08/2004 | WO2004056783A1 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
| 07/08/2004 | WO2004056782A1 Pyrazole compounds |
| 07/08/2004 | WO2004056735A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132794 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/08/2004 | US20040132793 5-{[3-Cyclopropyl-1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]oxy}isophthalonitrile; modulates, especially inhibits, reverse transcriptase; for treating AIDS |
| 07/08/2004 | US20040132785 Thiolesters and uses thereof |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | CA2511360A1 Novel pharmaceuticals |
| 07/08/2004 | CA2511325A1 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
| 07/08/2004 | CA2510850A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 07/08/2004 | CA2509403A1 Pyrazole compounds |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1073431B1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 07/07/2004 | EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 07/07/2004 | CN1511143A Herbicidal substituted benzoylpyrazoles |
| 07/07/2004 | CN1511142A Pyrazolecarboxamide derivative, intermediate therefor, and pest control agent containing same as active ingredient |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759538 Substituted diphenyl heterocycles useful for treating HCV infection |
| 07/06/2004 | US6759429 Having transforming growth factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/01/2004 | WO2004054982A1 Biphenylcarboxamides |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | US20040127710 Red luminescent compound and organic electroluminescent device using the same |
| 07/01/2004 | US20040127538 having an excellent JNK inhibitory action |
| 07/01/2004 | US20040127536 Indazole Derivatives |
| 07/01/2004 | US20040127526 elevating the HDL concentration and treating atherosclerosis and related coronary heart disease and dyslipoproteinemias |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
| 06/30/2004 | EP1432689A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 06/30/2004 | EP1432688A1 Insecticidal and acaricidal 3-substituted pyrazoles |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | CN1509171A Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases |
| 06/29/2004 | US6756497 Benzoic acid derivatives and processes for the preparation thereof |
| 06/29/2004 | US6756394 Small molecule inhibitors of necrosis |
| 06/24/2004 | WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them |
| 06/24/2004 | WO2004052865A1 Substituted pyrazoline carboxanilides for use as pesticides |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052849A1 Benzoyl derivative having sulfoximine group and herbicide |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004039306A3 Hair treatment composition containing a styryl-pyrazole compound |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122244 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |
| 06/24/2004 | US20040122075 N-phenyl-3-cyclopropylpyrazole-4-carbonitriles as ectoparasiticidal agents |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |